Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
2.84
-0.13 (-4.38%)
May 31, 2023, 4:00 PM EDT - Market closed
Relmada Therapeutics Stock Forecast
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for RLMD stock stock is $9.00, which predicts an increase of 216.90%. The lowest target is 8.00 and the highest is 10. On average, analysts rate RLMD stock stock as a hold.
Analyst Consensus: Hold
* Price targets were last updated on Jan 23, 2023.
Analyst Ratings
The average analyst rating for RLMD stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 5 | 4 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.72
from -5.30
EPS Next Year
-2.52
from -3.72
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 12.54M | 18.06M | 202.27M |
| Revenue Growth | - | - | - | - | - | - | - | - | 44.02% | 1,020.05% |
| EPS | -2.86 | -1.62 | -3.81 | -7.16 | -5.30 | -3.72 | -2.52 | -1.81 | -1.95 | -0.23 |
| EPS Growth | - | - | - | - | - | - | - | - | - | - |
| No. Analysts | - | - | - | - | - | 8 | 8 | 7 | 3 | 3 |
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | n/a | n/a | 64.5M | 31.8M | 208.2M |
| Avg | n/a | n/a | 12.5M | 18.1M | 202.3M |
| Low | n/a | n/a | n/a | n/a | 194.3M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | 153.7%
| 1,053.0%
|
| Avg | - | - | - | 44.0%
| 1,020.1%
|
| Low | - | - | - | - | 976.1%
|
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -2.55 | -1.85 | -1.17 | -2.01 | -0.24 |
| Avg | -3.72 | -2.52 | -1.81 | -1.95 | -0.23 |
| Low | -4.82 | -3.79 | -2.11 | -1.87 | -0.23 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.